Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patients
Authors:
Open Access
- 16 April 2025
- journal article
- review article
- Published by Springer Nature in Translational Neurodegeneration
- Vol. 14 (1) , 1-36
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease that remains incurable. Although the etiologies of ALS are diverse and the precise pathogenic mechanisms are not fully understood, approximately 20% of ALS cases are caused by genetic factors. Therefore, advancing targeted gene therapies holds significant promise, at least for the 20% of ALS patients with genetic etiologies. In this review, we summarize the main strategies and techniques of current ALS gene therapies based on ALS risk genes, and review recent findings from animal studies and clinical trials. Additionally, we highlight ALS-related genes with well-understood pathogenic mechanisms and the potential of numerous emerging gene-targeted therapeutic approaches for ALS.Keywords
Funding Information
- National Natural Science Foundation of China (81901273)
- Natural Science Foundation of Zhejiang Province (ZCLY24H0903)
This publication has 226 references indexed in Scilit:
- Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS modelNature Medicine, 2005
- Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse modelProceedings of the National Academy of Sciences, 2004
- VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS modelNature, 2004
- Gene therapy for ALS deliversTrends in Neurosciences, 2004
- Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS ModelScience, 2003
- Non-viral gene therapy: polycation-mediated DNA deliveryApplied Microbiology and Biotechnology, 2003
- Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress–induced death of motor neurons in amyotrophic lateral sclerosisAnnals of Neurology, 2002
- Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosisApoptosis, 2002
- Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systemsProceedings of the National Academy of Sciences, 2001
- Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factorsNature Medicine, 1997